3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow Stage II Ovarian Epithelial Cancer: new trials by email Literature Review of Stage II Ovarian Epithelial Cancer trials Research Report on Stage II Ovarian Epithelial Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia | Phase 2 | Terminated | City of Hope Medical Center | 1 | 2010-07-01 | 2019-06-18 |
| Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant ondansetron, survey administration, management of therapy complications - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission | Phase 2 | Completed | Fred Hutchinson Cancer Center | 49 | 2008-08-08 | 2017-05-23 |
| AZD2171 in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer cediranib maleate - Fallopian Tube Cancer, Primary Peritoneal Serous Adenocarcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 47 | 2005-10-01 | 2015-11-09 |
| EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer EF5 - Primary Peritoneal Cavity Cancer, Stage I Endometrial Carcinoma | Phase 2 | Completed | National Cancer Institute (NCI) | 60 | 2005-02-01 | 2013-01-16 |
Carcinoma, Ovarian Epithelial (4) · Blast Crisis (2) · Breast Neoplasms (2) · Burkitt Lymphoma (2) · Congenital Abnormalities (2) · Hodgkin Disease (2) · Leukemia, Hairy Cell (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myeloid, Accelerated Phase (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (2) · Leukemia, Myeloid, Chronic-Phase (2) · Leukemia, Myelomonocytic, Chronic (2) · Leukemia, Neutrophilic, Chronic (2) · Lymphoma, B-Cell, Marginal Zone (2)
Adnexal Diseases (4) · Carcinoma (4) · Endocrine Gland Neoplasms (4) · Endocrine System Diseases (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Neoplasms, Female (4) · Gonadal Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms by Site (4) · Neoplasms, Glandular and Epithelial (4) · Ovarian Diseases (4)
Deferasirox (1) · Ondansetron (1) · cediranib (1)
National Cancer Institute (NCI) (2) · City of Hope Medical Center (1) · Fred Hutchinson Cancer Center (1)
United States (4)
Christina Chu (1) · Leona Holmberg (1) · Ursula Matulonis (1) · Vinod Pullarkat, MD (1)
R21CA099346 (1), U01CA062490 (1)